The Functional Genomics Core (FGC), a key component of the COBRE, will enable current and future COBRE faculty to conduct high-throughput target discovery studies through phenotypic selection of Transdominant Genetic Inhibitors (TGIs). The FGC will also assist COBRE investigators with special molecular genetics and genomics techniques, including vector generation, lentiviral transduction, cell line modification, and gene expression analysis and profiling through QPCR, microarray analysis and RNA-Seq. The FGC will serve all four COBRE Projects via three Specific Aims:
Aim 1. Train the investigators and assist in the design and implementation of strategies for TGI-based target identification using transcriptome-scale lentiviral short hairpin RNA (shRNA) and Genetic Suppressor Elements (GSE) libraries. The FGC will provide several transcriptome-scale human shRNA and GSE libraries;conduct lentiviral transduction of TGI libraries into recipient cell lines;and assist the investigators with selection procedures. The FGC will also help produce """"""""focused"""""""" shRNA libraries of a subset of genes for preliminary high-throughput validation and prioritization of the targets identified in the initial selection, and help testing individual targets through shRNA transduction or siRNA transfection (Projects 1 and 3).
Aim 2. Assist COBRE investigators with genetic modification of cell lines for target or drug discovery or characterization through lentiviral transduction. The FGC will assist COBRE investigators in modifying cell lines for screening or analysis purposes. These modifications will include introducing fluorescent tags, promoter-reporter constructs, and the knockdown or overexpression of specific genes, in both stable and inducible formats (Projects 1, 3 and 4).
Aim 3. Carry out gene expression profiling and measurement for analyzing the effects of experimental compounds and genetic inhibitors. The FGC will provide microarray services on both Agilent and Affymetrix platforms and assist with the analysis of the microarray data. The Core will also prepare samples for RNA-Seq;interface with external Next-Gen sequencing facilities;assist with Next-Gen data analysis and with quantitative real-time reverse-transcription-PCR for validation of gene expression data (Projects 1, 2 and 3). The FGC will enable junior investigators to venture into areas of research that require sophisticated skills and years of experience, accelerating the pace of discovery and at the same time nurturing junior investigators into highly-skilled scientists.

Public Health Relevance

A precise determination of the role of genes and gene products in disease processes is critical to the identification of clinically relevant therapeutic targets for a variety of diseases. Functional Genomics approaches provide an effective way to rapidly derive reliable information about the function of genes and gene products that can be controlled very specifically, and therefore with fewer side effects, by drugs.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
1P20GM109091-01
Application #
8653306
Study Section
Special Emphasis Panel (ZGM1-TWD-A (C1))
Project Start
Project End
Budget Start
2014-07-10
Budget End
2015-04-30
Support Year
1
Fiscal Year
2014
Total Cost
$165,296
Indirect Cost
$52,466
Name
University of South Carolina at Columbia
Department
Type
DUNS #
041387846
City
Columbia
State
SC
Country
United States
Zip Code
29208
Jenkins, Laura M; Singh, Priyanka; Varadaraj, Archana et al. (2016) Altering the Proteoglycan State of Transforming Growth Factor β Type III Receptor (TβRIII)/Betaglycan Modulates Canonical Wnt/β-Catenin Signaling. J Biol Chem 291:25716-25728
Piroli, Gerardo G; Manuel, Allison M; Clapper, Anna C et al. (2016) Succination is Increased on Select Proteins in the Brainstem of the NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) Knockout Mouse, a Model of Leigh Syndrome. Mol Cell Proteomics 15:445-61
Jeong, Ha-Won; Choi, Ran Hee; McClellan, Jamie L et al. (2016) Tribbles 3 inhibits brown adipocyte differentiation and function by suppressing insulin signaling. Biochem Biophys Res Commun 470:783-91
Cheng, Bei; He, Huacheng; Huang, Tao et al. (2016) Gold Nanosphere Gated Mesoporous Silica Nanoparticle Responsive to Near-Infrared Light and Redox Potential as a Theranostic Platform for Cancer Therapy. J Biomed Nanotechnol 12:435-49
Hegde, Shweta; Ji, Hao; Oliver, David et al. (2016) PDE11A regulates social behaviors and is a key mechanism by which social experience sculpts the brain. Neuroscience 335:151-69
He, Huacheng; Altomare, Diego; Ozer, Ufuk et al. (2016) Cancer cell-selective killing polymer/copper combination. Biomater Sci 4:115-20
Rai, R; Zhang, F; Colavita, K et al. (2016) Arginyltransferase suppresses cell tumorigenic potential and inversely correlates with metastases in human cancers. Oncogene 35:4058-68
Kindy, Mark S; Yu, Jin; Zhu, Hong et al. (2016) A therapeutic cancer vaccine against GL261 murine glioma. J Transl Med 14:1
Broude, Eugenia V; Győrffy, Balázs; Chumanevich, Alexander A et al. (2015) Expression of CDK8 and CDK8-interacting Genes as Potential Biomarkers in Breast Cancer. Curr Cancer Drug Targets 15:739-49
Gomez, Adrian M; Altomare, Diego; Sun, Wei-Lun et al. (2015) Prefrontal microRNA-221 Mediates Environmental Enrichment-Induced Increase of Locomotor Sensitivity to Nicotine. Int J Neuropsychopharmacol 19:

Showing the most recent 10 out of 20 publications